Lung volumes predict survival in patients with chronic lung allograft dysfunction

被引:35
|
作者
Kneidinger, Nikolaus [1 ]
Milger, Katrin [1 ]
Janitza, Silke [2 ]
Ceelen, Felix [1 ]
Leuschner, Gabriela [1 ]
Dinkel, Julien [3 ]
Koenigshoff, Melanie [4 ]
Weig, Thomas [5 ]
Schramm, Rene [6 ]
Winter, Hauke [7 ]
Behr, Juergen [1 ]
Neurohr, Claus [1 ]
机构
[1] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[3] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Inst Clin Radiol, Munich, Germany
[4] German Ctr Lung Res DZL, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr CPC M, Res Unit Lung Repair & Regenerat, Munich, Germany
[5] Univ Munich, Dept Anaesthesiol, Munich, Germany
[6] Univ Munich, Clin Cardiac Surg, Munich, Germany
[7] Univ Munich, Dept Thorac Surg, Munich, Germany
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; TRANSPLANTATION; HYPERINFLATION; MORTALITY; ONSET;
D O I
10.1183/13993003.01315-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD. A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95). Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes. Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] ALVEOLAR FIBROELASTOSIS IN CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Braubach, P.
    Werlein, C.
    Maerzke, I.
    Kuehnel, M.
    Laenger, F.
    Jonigk, D.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 18 - 18
  • [42] The Role of Galectins in Chronic Lung Allograft Dysfunction
    D'Alessandro, Miriana
    Bergantini, Laura
    Fossi, Antonella
    De Vita, Elda
    Perillo, Felice
    Luzzi, Luca
    Paladini, Piero
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    Bennett, David
    LUNG, 2021, 199 (03) : 281 - 288
  • [43] Airway Alterations in Chronic Lung Allograft Dysfunction
    Verleden, S. E.
    Vasilescu, D.
    Willems, S.
    Ruttens, D.
    Vos, R.
    Vandermeulen, E.
    Mcdonough, J.
    Verbeken, E.
    Verschakelen, J.
    Van Raemdonck, D.
    Rondelet, B.
    Knoop, C.
    Decramer, M.
    Cooper, J.
    Hogg, J.
    Hostens, J.
    Verleden, G.
    Vanaudenaerde, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S105 - S106
  • [44] The diagnosis and management of chronic lung allograft dysfunction
    Verleden, Geert M.
    Hendriks, Jeroen M. H.
    Verleden, Stijn E.
    CURRENT OPINION IN PULMONARY MEDICINE, 2024, 30 (04) : 377 - 381
  • [45] Chronic lung allograft dysfunction: evolving practice
    Vos, Robin
    Verleden, Stijn E.
    Verleden, Geert M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (05) : 483 - 491
  • [46] Transglutaminase 2 in Chronic Lung Allograft Dysfunction
    Tissot, A.
    Brouard, S.
    Berthelot, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S512 - S512
  • [47] Emerging biomarkers in chronic lung allograft dysfunction
    Shtraichman, Osnat
    Diamond, Joshua M.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (05) : 467 - 475
  • [48] Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients
    Siddiqui, Atif S.
    Kumar, Gagan
    Majumdar, Tilottama
    Graviss, Edward A.
    Nguyen, Duc T.
    Goodarzi, Ahmad
    Kaleekal, Thomas
    CLINICAL TRANSPLANTATION, 2018, 32 (10)
  • [49] Clinical Characteristics of Patients with Chronic Lung Allograft Dysfunction Listed for Lung Re-Transplant
    Charoenpong, P.
    Adedeji, A.
    Daoud, N.
    Song, D.
    Ford, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S304 - S304
  • [50] Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
    Ram, Sundaresh
    Verleden, Stijn E.
    Bell, Alexander J.
    Hoff, Benjamin A.
    Labaki, Wassim W.
    Murray, Susan
    Vanaudenaerde, Bart M.
    Vos, Robin
    Verleden, Geert M.
    Kazerooni, Ella A.
    Galban, Stefanie
    Hatt, Charles R.
    Han, Meilan K.
    Lama, Vibha N.
    Galban, Craig J.
    CELLS, 2022, 11 (04)